The stock's overall trend over the past six months has been volatile but slightly negative, with a 6-month price change of -2.30%. The price has traded within a wide range, from a low near $145.59 in early November to a high of $175.10 in late January. Short-term performance has been weak, with the stock down 4.17% over the past month and 2.89% over the past three months, underperforming the broader market (SPY) which was down 5.25% and 4.63% over the same periods, respectively. The current price of $157.28 is near the middle of its 52-week range of $143.17 to $189.35, representing a discount of approximately 17% from the high. The stock has shown relative strength against the market over the past month and three months, with relative strength figures of 1.08 and 1.74, respectively.

Revenue in the latest quarter (Q4 2025) was $3.14 billion, showing a year-over-year growth of 3.63% from the $3.03 billion in Q4 2024. Profitability remains strong, with a net margin of 26.15% for the quarter and an operating margin of 38.74%. The company maintains a solid financial position with a debt-to-equity ratio of 0.70, indicating moderate leverage, and robust cash flow generation with free cash flow of $4.29 billion over the trailing twelve months. Operational efficiency is demonstrated by a Return on Equity (ROE) of 11.43% and a Return on Assets (ROA) of 2.26%, reflecting effective use of shareholder capital and company assets.